The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 12, 1998, Pages 3251-3255

  Swaney, Steve M ^a   Aoki, Hiroyuki ^b   Ganoza, M Clelia ^b   Shinabarger, Dean L ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; INITIATION FACTOR 1; INITIATION FACTOR 2; INITIATION FACTOR 3; KASUGAMYCIN; LINEZOLID; MESSENGER RNA; OXAZOLIDINONE DERIVATIVE; TRANSFER RNA;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL METABOLISM; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RIBOSOME SUBUNIT; RNA BINDING; STAPHYLOCOCCUS AUREUS;

EID: 0031729229     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.12.3251     Document Type: Article

References (28)

1. Brickner, S. J., D. K. Hutchinson, M. R. Barbachyn, P. R. Manninen, D. A. Ulanowicz, S. A. Garmon, K. C. Grega, S. K. Hendges, D. S. Toops, G. E. Zurenko, and C. W. Ford. 1996. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. J. Med. Chem. 39:673-679.
2. Burghardt, H., K. L. Schimz, and M. Muller. 1998. On the target of a novel class of antibiotics, oxazolidinones, active against multidiug-resistant gram-positive bacteria. FEBS Lett. 425:40-44.
3. Buysse, J. M., W. F. Demyan, D. S. Dunyak, D. Stapert, J. C. Hamel, and C. W. Ford. 1996. Mutation of the AcrAB antibiotic efflux pump in Escherichia coli confers susceptibility to oxazolidinone antibiotics, abstr. C-42, p. 41. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, D.C.
4. Daly, J. S., G. M. Eliopoulos, S. Wiley, and R. C. Moellering, Jr. 1988. Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound. Antimicrob. Agents Chemother. 32:1341-1346.
5. Eustice, D. C., P. A. Feldman, and A. M. Slee. 1988. Mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis. Biochem. Biophys. Res. Commun. 150:965-971.
6. Eustice, D. C., P. A. Feldman, I. Zajac, and A. M. Slee. 1988. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Antimicrob. Agents Chemother. 32:1218-1222.
7. Ford, C. W., J. C. Hamel, U. M. Wilson, J. K. Moerman, D. Stapert, R. J. Yancey, Jr., D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrob. Agents Chemother. 40:1508-1513.
8. Ganoza, M. C., H. Aoki, N. Burkhardt, and B. J. Murphy. 1996. The ribosome as "affinity matrix": efficient purification scheme for translation factors. Biochimie 78:51-61.
9. Ganoza, M. C., N. Barracluogh, and J. T. Wong. 1976 Purification and properties of an N-formylmethionyl-tRNA hydrolase. Eur. J. Biochem. 65: 613-622.
10. Gold, L. 1988. Post-transcriptional regulatory mechanisms in E. coli. Annu. Rev. Biochem. 57:199-233.
11. Gualerzi, C. O., M. Severini, R. Spurio, A. La Teana, and C. L. Pon. 1991. Molecular dissection of translation initiation factor IF2. J. Biol. Chem. 266: 16356-16362.
12. Gualerzi, C. O., A. L. Teana, R. Spurio, M. A. Canonaco, M. Severini, and C. L. Pon. 1990. Initiation of protein biosynthesis of procaryotes: recognition of mRNA by ribosomes and molecular basis for the function of the initiation factors, p. 281-291. In W. E. Hill (ed.), The ribosome: structure, function, and evolution. American Society for Microbiology, Washington, D.C.
13. Hershey, J. W. B., J. Yanov, and Z. Fakunding. 1979. Purification of protein synthesis initiation factors IF1, IF2, and IF3 from Escherichia coli. Methods Enzymol. 60:3-11.
14. Jones, R. N., D. M. Johnson, and M. E. Erwin. 1996. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob. Agents Chemother. 40:720-726.
15. Kaatz, G. W., and S. M. Seo. 1996. In vitro activities of oxazolidinone compounds U-100592 and U-100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 40:799-801.
16. Kreiswirth, B. N., S. Lofdahl, M. J. Betley, M. O'Reilly, P. M. Shlievert, M. S. Bergdoll, and R. P. Novick. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by prophage. Nature 305:709-712.
17. Lin, A. H., R. W. Murray, R. D. Schaadt, G. E. Zurenko, D. S. Dunyak, J. M. Buysse, and K. R. Marotti. 1997. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob. Agents Chemother. 41:2127-2131.
18. Mason, E. O., L. B. Lamberth, and S. L. Kaplan. 1996. In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:1039-1040.
19. Murray, R. W., R. D. Schaadt, G. E. Zurenko, and K. R. Marotti. 1998. Ribosomes from an oxazolidinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay. Antimicrob. Agents Chemother. 42:947-950.
20. Nielson, T., R. J. Gregoire, A. R. Fraser, E. C. Kofoid, and M. C. Ganoza. 1979. Synthesis of biologically active portions of an intercistronic region by use of a new 3′-phosphate incorporation method to protect 3′-OH and their binding to ribosomes. Eur. J. Biochem. 99:489-437.
21. Okuyama, A., N. Machiyama, T. Kinoshita, and N. Tanaka. 1971. Inhibition by kasugamycin of initiation complex formation on 30S ribosomes. Biochem. Biophys. Res. Commun. 43:196-199.
22. Rheinberger, H. J., U. Geigenuller, M. Wedde, and K. H. Nierhaus. 1988. Parameters for the preparation of Escherichia coli ribosomes and ribosomal subunits active in tRNA binding. Methods Enzymol. 164:659-662.
23. Samaha, R. R., R. Green, and H. F. Noller. 1995. A base pair between tRNA and 23S rRNA in the peptidyl transferase centre of the ribosome. Nature 377:309-314.
24. Sandhu, G. S., R. A. Aleff, and B. C. Kline. 1992. Dual asymmetric PCR: one-step construction of synthetic genes. BioTechniques 12:14-16.
25. Shinabarger, D. L., K. R. Marotti, R. W. Murray, A. H. Lin, E. P. Melchior, S. M. Swaney, D. S. Dunyak, W. F. Demyan, and J. M. Buysse. 1997. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob. Agents Chemother. 41:2132-2136.
26. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, M. J. Zawada, P. T. Bartholomew, W. A. Gregory, and M. Forbes. 1987. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP105 and DuP721. Antimicrob. Agents Chemother. 31:1791-1797.
27. Staehelin, T., and D. R. Maglott. 1971. Preparation of Escherichia coli ribosomal subunits active in polypeptide synthesis. Methods Enzymol. 20:449-455.
28. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, J. O. Kilburn, S. E. Glickman, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:839-845.